中文

Increase the probability
of your products' success

Words from the Founder

Words from the Founder

The Chinese pharmaceuticals industry has reached a historic turning point in the era of innovation, filled with exciting opportunities and challenges. This new shift calls for new requirements from Chinese CROs. First, quality should be paramount. Clinical trials must be implemented in accordance with international standards at the highest quality. We partner at all stages of the conception, design, and execution of clinical trials for new drug development.


dMed has emerged as a distinctive provider in this market, shouldering the inescapable responsibilities of the industry. dMed has gathered a talented and experienced team with a strong sense of ownership and collaboration to help drug developers accelerate progress and improve their success rates.


Dr. Lingshi Tan, Chairman & CEO

780 Cailun Road, 6/F, Q Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5155
沪ICP备16041651号-1 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号